chr2-47369555-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002354.3(EPCAM):c.50C>T(p.Thr17Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000598 in 1,588,400 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002354.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPCAM | NM_002354.3 | c.50C>T | p.Thr17Met | missense_variant | 1/9 | ENST00000263735.9 | NP_002345.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPCAM | ENST00000263735.9 | c.50C>T | p.Thr17Met | missense_variant | 1/9 | 1 | NM_002354.3 | ENSP00000263735.4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000148 AC: 3AN: 202956Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 110944
GnomAD4 exome AF: 0.0000654 AC: 94AN: 1436280Hom.: 0 Cov.: 31 AF XY: 0.0000575 AC XY: 41AN XY: 712494
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 24, 2018 | The p.Thr17Met variant in EPCAM has not been previously reported in affected ind ividuals. This variant has been reported as a variant of uncertain significance in ClinVar (Variation ID# 188106) and has been identified in 0.007% (1/14976) of European chromosomes by the gnomAD (http://gnomad.broadinstitute.org). Computat ional prediction tools and conservation analysis suggest that the p.Thr17Met var iant may not impact the protein, though this information is not predictive enoug h to rule out pathogenicity. In summary, this variant is unlikely to be causativ e for autosomal dominant Lynch syndrome which is due to loss of the translation termination signal but it is uncertain significance for autosomal recessive cong enital tufting enteropathy which can be caused by missense and loss of function variants. ACMG/AMP Criteria applied: PM2, BP4. - |
Lynch syndrome 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | St. Jude Molecular Pathology, St. Jude Children's Research Hospital | Aug 17, 2023 | The EPCAM c.50C>T (p.Thr17Met) missense variant has a maximum subpopulation frequency of 0.003% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). The in silico tool REVEL predicts a benign effect on protein function, but to our knowledge this prediction has not been confirmed by functional studies. To our knowledge, this variant has not been reported in individuals with EPCAM-related disease. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. - |
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 02, 2021 | This sequence change replaces threonine with methionine at codon 17 of the EPCAM protein (p.Thr17Met). The threonine residue is weakly conserved and there is a moderate physicochemical difference between threonine and methionine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with EPCAM-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at